Modern Chinese Medicine Group Co., Ltd. has issued a revised proxy form outlining the agenda for its annual general meeting (AGM), which will be held on 29 May 2026 at 10:00 a.m. in Shijiazhuang, Hebei Province.

Key ordinary resolutions to be voted on include: • Adoption of the audited consolidated financial statements and directors’ and auditor’s reports for the financial year ended 31 December 2025. • Re-election of Executive Director Ms. Sun Xinlei and Independent Non-Executive Director Ms. Liu Ling. • Authorisation for the board to determine directors’ remuneration. • Re-appointment of Forvis Mazars CPA Limited as external auditor and authorisation for the board to set its remuneration. • Granting of a 10% share repurchase mandate based on the total issued share capital at the date of the AGM. • Granting of a 20% general issuance mandate and, conditional on the repurchase mandate, an extension of the issuance mandate by the number of shares repurchased.

A special resolution proposes amendments to, and the adoption of, a new set of articles of association.

Shareholders wishing to vote by proxy must lodge the revised proxy form with Tricor Investor Services Limited by 10:00 a.m. on 27 May 2026. Completion of the proxy form does not preclude shareholders from attending and voting in person, in which case any previously submitted proxy will be revoked.